Addus HomeCare (NASDAQ:ADUS) EVP Darby Anderson Sells 396 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Darby Anderson sold 396 shares of the company’s stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $41,722.56. Following the completion of the transaction, the executive vice president owned 46,246 shares in the company, valued at approximately $4,872,478.56. This represents a 0.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Darby Anderson also recently made the following trade(s):

• On Tuesday, February 24th, Darby Anderson sold 733 shares of Addus HomeCare stock. The shares were sold at an average price of $106.98, for a total transaction of $78,416.34.

Addus HomeCare Trading Down 0.5%

NASDAQ ADUS traded down $0.51 on Friday, reaching $103.52. The stock had a trading volume of 14,471 shares, compared to its average volume of 233,037. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. The stock has a fifty day moving average price of $109.41 and a two-hundred day moving average price of $113.01. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $124.43. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of 19.85, a P/E/G ratio of 1.49 and a beta of 0.91.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the stock. KeyCorp reiterated an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. Truist Financial set a $135.00 price objective on shares of Addus HomeCare and gave the company a “buy” rating in a report on Wednesday, January 7th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. Wall Street Zen raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research report on Monday. Finally, Stephens cut their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $134.33.

Institutional Investors Weigh In On Addus HomeCare

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Capital Research Global Investors lifted its position in shares of Addus HomeCare by 22.3% during the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after purchasing an additional 268,192 shares during the last quarter. Vanguard Group Inc. increased its holdings in Addus HomeCare by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock valued at $140,531,000 after buying an additional 10,501 shares during the last quarter. Wasatch Advisors LP raised its stake in Addus HomeCare by 0.8% in the third quarter. Wasatch Advisors LP now owns 936,243 shares of the company’s stock valued at $110,467,000 after buying an additional 7,089 shares in the last quarter. State Street Corp lifted its holdings in Addus HomeCare by 0.9% during the 4th quarter. State Street Corp now owns 702,229 shares of the company’s stock worth $75,412,000 after buying an additional 6,561 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Addus HomeCare by 1.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 667,256 shares of the company’s stock worth $78,729,000 after buying an additional 7,884 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Stephens retained an “Overweight” rating on ADUS and set a $135 price target (trimmed from $140), keeping a constructive analyst opinion that supports medium-term upside. Read More.
• Positive Sentiment: Large institutional investors increased positions in recent quarters (Capital Research, Vanguard, Wasatch, State Street and others), signaling continued institutional confidence and buying power underneath the stock. Read More.
• Neutral Sentiment: Short-interest reporting is inconsistent across feeds (some entries show 0 shares, others show a material rise), creating data noise — investors should confirm with official FINRA/exchange data before sizing positions. Read More.
• Negative Sentiment: Insiders sold multiple tranches of stock on Feb. 24–25: CEO R. Dirk Allison sold several thousand shares (~7,300 across filings) and numerous EVPs also liquidated positions — concentrated insider selling often weighs on sentiment and can pressure the share price. Read More.
• Negative Sentiment: Reported short interest increased materially in February to roughly 1.15M shares (~6.5% of float, ~4.6 days to cover in mid-February) — a larger short book can amplify downside on negative headlines and increase volatility. Read More.
• Negative Sentiment: Media picked up a “pessimistic forecast” narrative tied to Stephens’ shorter-term expectations after the PT cut, which can reinforce selling pressure despite the retained Overweight rating. Read More.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.